NCT06800612View on ClinicalTrials.gov

Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 22, 2024

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer MetastaticOvarian CancerCervical CarcinomaEndometrial Cancer
Interventions
DRUG

Oncologic drugs administered for treatment of breast cancer

Data on oncologic drugs administered for treatment of breast cancer will be recorded

DRUG

Oncologic drug administered for treatment of gynecologic cancer

Data on oncologic drugs administered for treatment of gynecologic cancer will be recorded

Trial Locations (1)

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna

All Listed Sponsors
lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER